Soluble CSF interleukin 2 receptor as indicator of neurosarcoidosis
- 17 June 2010
- journal article
- research article
- Published by Springer Nature in Journal of Neurology
- Vol. 257 (11) , 1855-1863
Abstract
Neurosarcoidosis (NS) represents an important differential diagnosis of multiple sclerosis (MS). However, thus far no reliable laboratory marker of neurosarcoidosis exists. The objective of this study was to evaluate whether cerebrospinal fluid (CSF) levels of soluble interleukin 2 receptor (sIL2-R) distinguish NS and other inflammatory disorders of the central nervous system. For this purpose, 139 paired CSF and serum samples from 11 patients with NS, 21 with MS, 10 with CNS vasculitis, 22 with bacterial meningitis, 17 with viral meningitis/encephalitis, seven with neurotuberculosis, and 18 healthy donors were assessed for sIL2-R using an enzyme-linked immunosorbent assay. We found that sIL2-R CSF levels above 150 pg/ml identified untreated NS patients with an overall accuracy of 93% against a group of non-infectious CNS-diseases. Furthermore, an increase in sIL2-R in the CSF was associated with and preceded the outbreak of new neurological symptoms. In conclusion, these findings suggest that sIL2-R measurement in the CSF may be a valuable tool in the diagnosis and follow-up of patients with suspected and proven neurosarcoidosis.Keywords
This publication has 15 references indexed in Scilit:
- Neurosarcoidosis: a study of 30 new casesJournal of Neurology, Neurosurgery & Psychiatry, 2009
- Cerebrospinal Fluid Angiotensin-Converting Enzyme for Diagnosis of Central Nervous System SarcoidosisThe Neurologist, 2009
- NeurosarcoidosisJournal of Neurology, 2005
- Serum Soluble Interleukin-2 Receptor Measurement in Patients With SarcoidosisChest, 2003
- Diagnosis and management of neurosarcoidosisJournal of Clinical Neuroscience, 2001
- Central nervous system sarcoidosisdiagnosis and managementQJM: An International Journal of Medicine, 1999
- Correlation of Clinical and Immunologic Parameters of the Inflammatory Activity of Pulmonary SarcoidosisAmerican Review of Respiratory Disease, 1991
- Serum Concentration of Soluble lnterleukin-2 Receptor as a Sensitive Parameter of Disease Activity in SarcoidosisChest, 1990
- Soluble interleukin 2 receptors are released from activated human lymphoid cells in vitro.The Journal of Immunology, 1985
- The Prevalence of Sarcoidosis in the Autopsy Material from a Swedish TownActa Medica Scandinavica, 1964